|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: EDEN BIOSCIENCE CORP, S-1, EX-23.3, 2000-07-07 |
Next: ICN PHARMACEUTICALS INC, 10-Q/A, 2000-07-07 |
<TABLE> <S> <C>
<ARTICLE> 5
<S> <C>
<PERIOD-TYPE> YEAR
<FISCAL-YEAR-END> DEC-31-1999
<PERIOD-START> JAN-01-1999
<PERIOD-END> DEC-31-1999
<CASH> 13,107,250
<SECURITIES> 0
<RECEIVABLES> 0
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 13,168,617
<PP&E> 4,549,856
<DEPRECIATION> 1,600,136
<TOTAL-ASSETS> 16,278,048
<CURRENT-LIABILITIES> 2,154,814
<BONDS> 0
0
97,464
<COMMON> 6,737
<OTHER-SE> 13,496,067
<TOTAL-LIABILITY-AND-EQUITY> 16,278,048
<SALES> 0
<TOTAL-REVENUES> 114,620
<CGS> 0
<TOTAL-COSTS> 0
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 181,159
<INCOME-PRETAX> 9,394,578
<INCOME-TAX> 0
<INCOME-CONTINUING> 9,394,578
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 9,394,578
<EPS-BASIC> (5.23)
<EPS-DILUTED> (5.23)
</TABLE>
|
|